Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-04

Clinical Trial Update: Curcumin Bioavailability in Glioblastoma Patients

View source ↗

Summary

A completed clinical trial evaluated the bioavailability of curcumin in patients with glioblastoma undergoing surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Patient Harboring Glioblastoma That Will Undergo Surgery | Status: COMPLETED